ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2024 Annual Eric Dostie Memorial College Scholarship Recipients

TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship recipients. The annual scholarship program grants 10 awards of $1,000 to qualifying students affected by hemophilia who can best demonstrate scholastic achievement, community service, and financial need.

Congratulations to our 2024 Eric Dostie Memorial College Scholarship recipients:

  • Caleb Merson
  • Elisabeth Norman
  • Fatima Celis Galindo
  • Inika Singh
  • James Hensley
  • Jocelyn Doerr
  • Karissa Doerr
  • Michael White
  • Tyler Loftus
  • Yohance de Souza 

The scholarship was created to honor the memory of 5-year-old Eric Dostie, a boy with hemophilia who was tragically murdered on August 27, 1994. Awards will provide financial assistance to students who have hemophilia or a similar bleeding disorder, or who have a family member with a bleeding disorder and meet other scholarship qualifications.

Patrick M. Schmidt, chief executive officer of FFF Enterprises, said, “I congratulate each of these deserving Eric Dostie Memorial College Scholarship recipients and wish them much success. It’s inspiring to think of all the good things they can accomplish in college and beyond.”

As part of the application process, applicants submitted an essay describing how their education will be used to serve humankind and encourage self-improvement and enrichment.

Applications for the 2025 Eric Dostie Memorial College Scholarship will be available for submission starting Friday, November 8, 2024. Visit the Nufactor Eric Dostie Memorial College Scholarship website to learn more about the program.

About Nufactor, Inc.
Nufactor, Inc. is a specialty infusion company and subsidiary of FFF Enterprises, Inc., the largest and most trusted specialty pharmaceutical distributor and diversified healthcare organization. Established in 1995, Nufactor offers safe, convenient, and reliable home infusion solutions for patients receiving immunoglobulin, plasminogen, antihemophilic factor, and infliximab. Nufactor has earned The Joint Commission’s Gold Seal of Approval®, URAC’s Specialty Pharmacy Accreditation, and is a URAC Certified Rare Disease Pharmacy Center of Excellence. Please visit LinkedIn, Instagram, Facebook, and YouTube for more information about the company.

About FFF Enterprises, Inc.
Founded in 1988, FFF Enterprises, Inc. is a privately held, multibillion-dollar specialty pharmaceutical distributor and diversified healthcare organization. FFF Enterprises is the parent company to leading specialty infusion company Nufactor, Inc., as well as InCircle, LLC and RightNow Inventory™. Our partners include global pharmaceutical and biologics manufacturers, prestigious healthcare systems, large and independent retail pharmacies, and leading alternate care sites. Our nationwide commerce is supported by a network of distribution and infusion pharmacy locations utilizing world-class technology and cybersecurity solutions. Please visit FFF Enterprises’ news site, as well as LinkedIn, X, Facebook, Instagram, and YouTube for more information about the company.

Attachment


Michelle Valenzuela
FFF Enterprises.com
(951) 296-2528 ext 1410
mvalenzuela@fffenterprises.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.